REVIEW
Published on 09 Jan 2024
Wnt/β-catenin signaling pathway in the tumor progression of adrenocortical carcinoma
doi 10.3389/fendo.2023.1260701
- 1,689 views
- 2 citations
- Frontiers in Endocrinology
- Cancer Endocrinology
- Research Topics
- Adrenocortical Carcinoma: Advancing treatment beyond surgery for a rare disease
Adrenocortical Carcinoma: Advancing treatment beyond surgery for a rare disease
3,823
Total downloads
12k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 08 Jan 2024
Efficacy and safety of adjuvant radiation therapy in localized adrenocortical carcinoma
doi 10.3389/fendo.2023.1308231
- 887 views
- 1 citation
ORIGINAL RESEARCH
Published on 08 Dec 2023
A reappraisal of transcriptional regulation by NR5A1 and beta-catenin in adrenocortical carcinoma
doi 10.3389/fendo.2023.1303332
- 1,069 views
CASE REPORT
Published on 08 Sep 2023
Case Report: Response to ipilimumab and nivolumab in a patient with adrenocortical carcinoma
doi 10.3389/fonc.2023.1242560
- 1,539 views
- 1 citation
BRIEF RESEARCH REPORT
Published on 14 Aug 2023
Neurological adverse events of mitotane in adrenocortical carcinoma: results of a pilot study
doi 10.3389/fonc.2023.1222002
- 1,420 views
- 1 citation
ORIGINAL RESEARCH
Published on 10 Mar 2023
Prognostic predictors of adrenocortical carcinoma: A single-center thirty-year experience
doi 10.3389/fendo.2023.1134643
- 1,584 views
- 2 citations
ORIGINAL RESEARCH
Published on 30 Jan 2023
Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets
doi 10.3389/fendo.2023.1089531
- 1,866 views
- 2 citations
Published in
Frontiers in Endocrinology
- Cancer Endocrinology
Participating Journals
Frontiers in Oncology
Cancer EndocrinologyOffline
- 3.5 impact factor
- 6.2 citescore
Impact
- 12kTopic views
- 8,373Article views
- 3,823Article downloads